3 days ago
1
The recent decease of 2 radical successful Brazil during its dengue vaccination campaign, starring to the shot’s suspension connected June 8, is simply a important wake-up telephone for India. This is due to the fact that the dengue vaccine successful Brazil, Butantan-DV, is beauteous similar, if not identical, to India’s soon-to-be-launched dengue vaccine, DengiAll.
Both the Brazilian and Indian vaccines person been respective years successful the making. Both are made up of unrecorded but weakened (attenuated) versions of dengue viruses (DENVs). And some vaccines are said to beryllium tetravalent due to the fact that each vaccine is successful information a carnal substance of 4 live, weakened DENVs.
GBA appeals for nationalist practice successful dengue control
Indeed, DENVs travel successful 4 versions, oregon serotypes: called DENV-1, -2, -3 and -4. All 4 serotypes are known to beryllium prevalent successful Brazil and India. Each DENV serotype has an outer ammunition adorned with specialised envelope proteins, called E proteins — akin to the spike macromolecule of coronaviruses. Even though the 4 DENV serotypes are precise similar, their E proteins are antithetic capable to warrant immunisation against each of the 4 serotypes.
Antibody-dependent enhancement
When weakened DENV is utilized successful a vaccine, it volition punctual respective kinds of antibodies that tin beryllium grouped into 2 classes: type-specific antibodies and cross-reactive antibodies. The type-specific antibodies, often made successful tiny amounts, are circumstantial to unsocial regions connected the E macromolecule of a fixed serotype. That is, the type-specific antibodies recognise lone 1 peculiar serotype and excel successful blocking infections by that serotype alone.
On the different hand, the cross-reactive antibodies are made usually successful ample amounts and are circumstantial to akin regions connected the E proteins of each 4 serotypes. That is, they tin recognise immoderate of the 4 serotypes and artifact an corruption — provided they are contiguous successful adequately precocious levels. When their levels decrease, the cross-reactive antibodies don’t conscionable neglect to artifact a caller DENV infection: they heighten it, starring to a terrible and perchance fatal signifier of dengue.
This improvement is called antibody-dependent enhancement (ADE). The hazard of imaginable ADE during dengue vaccination is considered a superior adverse event. If untreated it tin pb to death.
In Brazil’s dengue vaccination campaign, of 42 vaccine recipients who displayed superior side-effects, 2 radical died and 1 had to person intensive care. These side-effects included terrible abdominal pain, persistent vomiting, and bleeding, nary of which the signifier 3 objective trials revealed. These signs are disturbingly reminiscent of viral haemorrhagic fevers specified arsenic dengue successful its terrible form. Medical researchers should look into whether this could beryllium owed to ADE.
They should besides clarify if DengiAll volition manifest a akin hazard erstwhile it is rolled retired successful India.
Issues with Dengvaxia
Butantan-DV and DengiAll are some based connected the efforts of scientists astatine the U.S. National Institutes of Health (NIH). Over galore years, they separately weakened each DENV serotype to marque monovalent vaccines, assessed each 1 for its capableness to induce an immune effect without causing disease, and yet mixed each 4 monovalent vaccine viruses to make tetravalent vaccines. Two of them, called TV003 and TV005, and the monovalent vaccine viruses were licensed to Instituto Butantan successful Brazil and Panacea Biotec successful India, among others, for further development.
Butantan-DV is not the archetypal dengue vaccine to beryllium linked to specified events. A small implicit a decennary ago, Sanofi Pasteur developed the archetypal tetravalent dengue vaccine to beryllium licensed. It differed from the NIH’s TV003 and TV005 successful that the 4 weakened serotypes were hybrid viruses, each covered connected its aboveground with the E macromolecule of 1 of the DENV serotypes (plus different protein).
This shot, called Dengvaxia, was fixed to much than 8 lakh children successful the Phillipines, a dengue-endemic state similar Brazil and India. Severe adverse events occurred 3 years aft vaccination. Further survey revealed Dengvaxia worked similar a monovalent vaccine, provoking antibodies to lone a azygous serotype, DENV-4. That is, mixing 4 unrecorded yet weakened viruses to make a tetravalent vaccine didn’t automatically guarantee tetravalent immunity. Why? There is nary wide reply yet.
Taken together, the terrible adverse events linked to Butantan-DV rise galore questions. Is Butantan-DV truly functionally tetravalent? Is determination a anticipation of viral interference compromising its functionality? Could ADE beryllium the crushed for the perchance fatal outcomes successful 2 instances?
Gap successful signifier 3 trials
These questions are rendered much challenging by a lacuna successful the vaccine efficacy information collected successful the signifier 3 trials. Reports successful January 2024, November 2024, and March 2026 indicated that Butantan-DV’s efficacy against DENV-3 and DENV-4 is chartless arsenic these serotypes were not prevalent successful Brazil astatine the clip of the trials.
Panacea Biotec’s DengiAll signifier 3 trials, unneurotic with the Indian Council of Medical Research, completed its enrollment people of 10,335 steadfast volunteers successful January this year. The proceedings began successful August 2024; its participants volition beryllium followed for 2 years post-vaccination. Once each the information person been collected and analysed, the researchers (with the company) volition attack the Indian cause regulator for marketplace approval.
There is nary coagulated crushed to contradict that DengiAll whitethorn not look the perchance fatal issues that person travel up with Butantan-DV. However, India tin proactively bash immoderate things to mitigate information concerns up of DengiAll’s aboriginal rollout. First, Panacea indispensable analyse a typical subset of sera from vaccinated volunteers for type-specific antibodies against each 4 serotypes. And the cause regulator indispensable guarantee specified information is disposable and rules retired imaginable hazard of ADE.
Robust pharmacovigilance
Further, erstwhile DengiAll is launched, the regulator indispensable instrumentality a robust pharmacovigilance programme for an extended play of time. Vaccine recipients indispensable beryllium clinically monitored periodically and their humor indispensable beryllium collected astatine regular intervals to cheque for viruses, antibodies, and different parameters to instrumentality remedial measures quickly. Continuous real-world monitoring is cardinal to identifying uncommon oregon semipermanent adverse events.
The ADE concerns besides use to different tetravalent dengue vaccine, Qdenga, which is besides a carnal premix of 4 weakened versions of the DENV serotypes. Japan-based Takeda markets it and its India support is imminent.
Brazilian authorities person stressed that the 42 cases of terrible adverse events retired of half-a-million vaccinated correspond lone 0.008%. There is nary uncertainty that it is simply a tiny hazard astatine the colonisation level. At the idiosyncratic level, however, adjacent 1 beingness mislaid to a terrible adverse lawsuit is 1 excessively many.
S. Swaminathan is retired prof of biology from BITS Pilani-Hyderabad and a erstwhile idiosyncratic successful the country of dengue vaccinology astatine ICGEB, New Delhi.
